Asgard Therapeutics
SwedenEntry
2021
Hold
5yr
Status
Active
Who owns Asgard Therapeutics?
Asgard Therapeutics is currently owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage), since 2021. Across its history, Asgard Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-03
Most recent investor
Boehringer Ingelheim Venture FundBoehringer Ingelheim Venture Fund · 2010 · Evergreen
3 ownership periods · full history below
Key facts
HQSweden
SectorBiotech
StatusActive
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2021 · present
IndustrifondenActive
2021 · present(5yr) · Industrifonden Evergreen · 1991 · VC
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Seed Investments · 1999 · VC
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
US
Germany
Switzerland
France
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Asgard Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Asgard Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Asgard Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue